<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Daily Stocks News &#187; DDS</title>
	<atom:link href="http://news.dailystocks.com/tag/dds/feed/" rel="self" type="application/rss+xml" />
	<link>http://news.dailystocks.com</link>
	<description>Stocks with Insider Buying, Stock Search Engine, Glossary, Education, Reviews</description>
	<lastBuildDate>Mon, 21 Jan 2019 17:42:26 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>Dillard’s Reports Q1 Results (DDS)</title>
		<link>http://news.dailystocks.com/3004/dillards-reports-q1-results-dds/</link>
		<comments>http://news.dailystocks.com/3004/dillards-reports-q1-results-dds/#comments</comments>
		<pubDate>Fri, 17 May 2013 15:38:24 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[DDS]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=3004</guid>
		<description><![CDATA[<p>Dillard’s Inc. (NYSE: DDS), a fashion apparel, cosmetics and home furnishing retailer, has reported record results for the first quarter ended May 4, 2013. Despite the strong results, shares of the retailer are fluctuating between gains and losses in trading today.</p> <p></p> <p>For the first quarter, Dillard’s reported net income of $117.2 million, or $2.50 [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/3004/dillards-reports-q1-results-dds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Major Movers on February 25; ELN, DDD, HTZ, DDS</title>
		<link>http://news.dailystocks.com/2463/major-movers-on-february-25-eln-ddd-htz-dds/</link>
		<comments>http://news.dailystocks.com/2463/major-movers-on-february-25-eln-ddd-htz-dds/#comments</comments>
		<pubDate>Mon, 25 Feb 2013 14:59:27 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[DDD]]></category>
		<category><![CDATA[DDS]]></category>
		<category><![CDATA[ELN]]></category>
		<category><![CDATA[HTZ]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=2463</guid>
		<description><![CDATA[<p>Shares of Elan Corporation Plc (ADR) (NYSE: ELN), a neuroscience-based biotechnology company, are soaring in trading today after the company received a takeover offer from Royalty Pharma.</p> <p></p> <p>Royalty Pharma, which is an investment firm, has offered to acquire Elan for $6.6 billion. The investment firm has offered $11 per share to ELN, which represents [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/2463/major-movers-on-february-25-eln-ddd-htz-dds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Major Gainers and Losers on November 27; ACAD, MMR, CROX, THO, DDS</title>
		<link>http://news.dailystocks.com/1921/major-gainers-and-losers-on-november-27-acad-mmr-crox-tho-dds/</link>
		<comments>http://news.dailystocks.com/1921/major-gainers-and-losers-on-november-27-acad-mmr-crox-tho-dds/#comments</comments>
		<pubDate>Tue, 27 Nov 2012 19:27:30 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[ACAD]]></category>
		<category><![CDATA[CROX]]></category>
		<category><![CDATA[DDS]]></category>
		<category><![CDATA[MMR]]></category>
		<category><![CDATA[THO]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=1921</guid>
		<description><![CDATA[<p>Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focusing on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders, are seeing a huge rally in trading today.</p> <p></p> <p>At last check, ACAD shares were trading 143.70% higher at $5.61 on above average volume of 42.70 million. [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/1921/major-gainers-and-losers-on-november-27-acad-mmr-crox-tho-dds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
